Results 11 to 20 of about 405 (122)
Parasites and Vectors, 2017 Background Lotilaner (Credelio™, Elanco) is a novel isoxazoline that provides rapid speed of flea and tick knockdown which is sustained for at least 1 month following oral administration to dogs.
Emmanuelle A. Kuntz +1 more
exaly +4 more sources
Case Reports in Veterinary Medicine, 2021 Canine sarcoptic mange is a highly pruritic and contagious skin disease caused by the mite Sarcoptes scabiei var. canis. This case series describes the clinical, parasitological, and serological follow-up of a cohort of eight adult Saint Bernard dogs ...
F. Moog +3 more
doaj +3 more sources
Journal of Ophthalmology, 2021 Purpose. Evaluate safety and efficacy of topical lotilaner ophthalmic solution, 0.25% for the treatment of Demodex blepharitis. Patients and Methods. 15 patients with Demodex blepharitis, defined as >10 collarettes on the upper lid, lid margin erythema ...
Roberto Gonzalez-Salinas +8 more
doaj +3 more sources
Lotilaner Ophthalmic Solution 0.25%: First Approval [PDF]
Drugs, 2023 Declarations Funding The preparation of this review was not supported by any external funding. Authorship and Conflict of interest Yahiya Y. Syed is a salaried employee of Adis International Ltd/Springer Nature, and declares no relevant conflicts of ...
Syed YY.
exaly +3 more sources
Parasites & Vectors, 2017 Background Lotilaner is a novel isoxazoline developed for oral administration to dogs. In laboratory studies, lotilaner was shown to be safe and to produce a rapid flea and tick knockdown, with a sustained speed of kill for at least a month post ...
Daniela Cavalleri +4 more
doaj +2 more sources
The intravenous and oral pharmacokinetics of lotilaner in dogs
Parasites & Vectors, 2017 Background Lotilaner is a new oral ectoparasiticide from the isoxazoline class developed for the treatment of flea and tick infestations in dogs. It is formulated as pure S-enantiomer in flavoured chewable tablets (Credelio™).
Céline E. Toutain +2 more
doaj +2 more sources
Assessment of the onset of lotilaner (Credelio™) speed of kill of fleas on dogs
Parasites & Vectors, 2017 Background Lotilaner (Credelio™) is the newest member of the novel isoxazoline chemical class to be developed to treat canine ectoparasitism. Administered orally, lotilaner is rapidly absorbed with peak blood levels occurring within 2 h post-treatment. A
Daniela Cavalleri +4 more
doaj +2 more sources
A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA [PDF]
Parasites & Vectors, 2017 Background Preclinical studies have shown that the novel isoxazoline, lotilaner (Credelio™, Elanco) administered orally to dogs, produces rapid flea and tick knockdown and sustained speed of kill for at least a month post-treatment with a wide safety ...
Daniela Karadzovska +7 more
doaj +2 more sources
Parasites & Vectors, 2017 Background The oral systemic efficacy of lotilaner (Credelio™, Elanco) was evaluated against Demodex spp. in naturally infested dogs with generalized demodicosis.
Daniel E. Snyder +2 more
doaj +2 more sources
Parasites & Vectors, 2018 Background Lotilaner is approved for dogs as a chewable tablet formulation. It has separately been developed for oral administration in cats (Credelio™ chewable tablets for cats) to meet the need for an easy to use, safe and rapidly effective ...
Daniela Cavalleri +3 more
doaj +2 more sources